Holen Sie sich die Stockscreener-App
1.32
3.13%
0.04
Schlusskurs vom Vortag:
$1.28
Offen:
$1.28
24-Stunden-Volumen:
114.68K
Relative Volume:
0.25
Marktkapitalisierung:
$60.36M
Einnahmen:
$19.94M
Nettoeinkommen (Verlust:
$-37.37M
KGV:
-1.2692
EPS:
-1.04
Netto-Cashflow:
$-33.38M
1W Leistung:
-0.75%
1M Leistung:
-5.71%
6M Leistung:
-4.35%
1J Leistung:
-40.00%
1-Tages-Spanne:
$1.28
$1.37
1-Wochen-Bereich:
$1.20
$1.37
52-Wochen-Spanne:
$0.595
$4.18
Werewolf Therapeutics Inc Stock (HOWL) Company Profile
Firmenname
Werewolf Therapeutics Inc
Sektor
Branche
Telefon
617-952-0555
Adresse
200 TALCOTT AVENUE, WATERTOWN
Vergleichen Sie HOWL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HOWL
Werewolf Therapeutics Inc
|
1.32 | 59.68M | 19.94M | -37.37M | -33.38M | -1.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Werewolf Therapeutics Inc Stock (HOWL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-03 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-08-24 | Eingeleitet | Wedbush | Outperform |
| 2023-06-06 | Fortgesetzt | Jefferies | Buy |
| 2021-09-10 | Eingeleitet | BofA Securities | Buy |
| 2021-05-25 | Eingeleitet | Evercore ISI | Outperform |
| 2021-05-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-05-25 | Eingeleitet | Jefferies | Buy |
| 2021-05-25 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Werewolf Therapeutics Inc Aktie (HOWL) Neueste Nachrichten
What momentum shifts mean for Werewolf Therapeutics Inc.2025 Earnings Impact & Free Technical Pattern Based Buy Signals - Newser
Will Werewolf Therapeutics Inc. stock benefit from AI tech trends2025 Key Highlights & Daily Profit Maximizing Trade Tips - Newser
Statistical indicators supporting Werewolf Therapeutics Inc.’s strengthMarket Growth Review & Capital Protection Trading Alerts - Newser
Is Werewolf Therapeutics Inc. stock poised for growthEarnings Beat & Technical Buy Zone Confirmation - Newser
Is Werewolf Therapeutics Inc. meeting your algorithmic filter criteriaTreasury Yields & Weekly Hot Stock Watchlists - Newser
What recovery options are there for Werewolf Therapeutics Inc.2025 Technical Overview & Low Drawdown Trading Strategies - Newser
Why Werewolf Therapeutics Inc. stock attracts strong analyst attentionJuly 2025 Volume & Daily Chart Pattern Signal Reports - beatles.ru
Smart tools for monitoring Werewolf Therapeutics Inc.’s price actionJuly 2025 Market Mood & AI Forecasted Stock Moves - Newser
How to monitor Werewolf Therapeutics Inc. with trend dashboards2025 Trade Ideas & Weekly Hot Stock Watchlists - Newser
Custom watchlist performance reports with Werewolf Therapeutics Inc.GDP Growth & Verified High Yield Trade Plans - Newser
Strategies to average down on Werewolf Therapeutics Inc.2025 Bull vs Bear & Daily Oversold Bounce Ideas - Newser
Werewolf Therapeutics Inc. stock momentum explained2025 Market Outlook & Daily Volume Surge Trade Alerts - Newser
Using Bollinger Bands to evaluate Werewolf Therapeutics Inc.2025 Retail Activity & Low Drawdown Investment Strategies - Newser
Can momentum traders help lift Werewolf Therapeutics Inc.2025 Volatility Report & Low Drawdown Trading Techniques - Newser
What is HC Wainwright’s Estimate for HOWL Q3 Earnings? - Defense World
When is the best time to exit Werewolf Therapeutics Inc.Earnings Miss & Short-Term High Return Strategies - Newser
How institutional ownership impacts Werewolf Therapeutics Inc. stockEntry Point & Free Verified High Yield Trade Plans - Newser
Werewolf Therapeutics Faces Regulatory and Financial Challenges Amid FDA Disruptions - MSN
Real time alert setup for Werewolf Therapeutics Inc. performanceJuly 2025 Market Mood & Daily Oversold Stock Bounce Ideas - Newser
Why Werewolf Therapeutics Inc. is moving todayEarnings Recap Summary & Weekly Top Gainers Trade List - Newser
AI Tools Suggest Werewolf Therapeutics Inc. May Outperform This Week - sundaytimes.kr
Relative strength of Werewolf Therapeutics Inc. in sector analysisJuly 2025 Levels & Community Trade Idea Sharing Platform - Newser
Werewolf Reports No Revenue in Fiscal Q2 - AOL.com
Analyzing Werewolf Therapeutics Inc. with multi timeframe chartsDollar Strength & Fast Entry High Yield Stock Tips - Newser
Using Python tools to backtest Werewolf Therapeutics Inc. strategies2025 Market Sentiment & Short-Term High Return Ideas - Newser
Is Werewolf Therapeutics Inc. Stock a Good Fit for Conservative InvestorsJuly 2025 Price Swings & High Conviction Trade Alerts - Newser
Using data filters to optimize entry into Werewolf Therapeutics Inc.Market Trend Review & Community Verified Watchlist Alerts - Newser
Full technical analysis of Werewolf Therapeutics Inc. stockEarnings Overview Summary & AI Forecast Swing Trade Picks - Newser
Short interest data insights for Werewolf Therapeutics Inc.2025 Geopolitical Influence & Capital Protection Trading Alerts - Newser
Using economic indicators to assess Werewolf Therapeutics Inc. potentialPortfolio Profit Report & Smart Allocation Stock Tips - Newser
Is Werewolf Therapeutics Inc. backed by strong institutional buyingWeekly Earnings Recap & Smart Investment Allocation Insights - sundaytimes.kr
Using data models to predict Werewolf Therapeutics Inc. stock movementJobs Report & Technical Pattern Based Buy Signals - Newser
Werewolf Therapeutics reports Q2 EPS (40c), consensus (37c) - MSN
Werewolf Therapeutics Reports Q2 2025 Financial Results - MSN
Finanzdaten der Werewolf Therapeutics Inc-Aktie (HOWL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Werewolf Therapeutics Inc-Aktie (HOWL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Director |
May 14 '25 |
Buy |
0.98 |
162,539 |
159,288 |
6,237,482 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
May 13 '25 |
Buy |
0.98 |
52,974 |
51,915 |
6,074,943 |
| MPM BioVentures 2014, L.P. | 10% Owner |
Mar 27 '25 |
Sale |
1.05 |
1,963 |
2,061 |
3,208,793 |
| EVNIN LUKE | Director |
Mar 27 '25 |
Sale |
1.05 |
2,425 |
2,546 |
4,309,860 |
| GADICKE ANSBERT | 10% Owner |
Mar 27 '25 |
Sale |
1.05 |
4,386 |
4,605 |
6,718,670 |
0.94%
1.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):